Arcus Bioscience Announces First Overall Survival Results From Phase 2 Edge-Gastric Study
ReutersOct 12, 2025 10:10 PM
Oct 12 (Reuters) - Arcus Biosciences Inc RCUS.N:
ANTI-TIGIT DOMVANALIMAB PLUS ANTI-PD-1 ZIMBERELIMAB AND CHEMOTHERAPY SHOWED 26.7 MONTHS OF MEDIAN OVERALL SURVIVAL AS FIRST-LINE TREATMENT OF UNRESECTABLE OR ADVANCED GASTROESOPHAGEAL ADENOCARCINOMAS IN THE PHASE 2 EDGE-GASTRIC STUDY
ARCUS BIOSCIENCES INC - NO UNEXPECTED SAFETY SIGNALS OBSERVED IN STUDY
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Synopsys (SNPS): Strategic Opportunities and Risks Amid 40% Drawdown
Chip giant Synopsys teetering on the edge? The ultimate "pick-and-shovel" supplier in the AI frenzy, but hammered by China's sudden market freeze and export clamps, sending shares crashing 40%! Is that $35 billion Ansys mega-deal a rescue rope or a bigger sinkhole? Dive into the EDA powerhouse's naiTradingKey
Wed, Oct 8
-8a7a081ca049441dae56d6b7cc6440c4.jpg)
Is the UK Economy Headed for Collapse? Will Assets Face a "Triple Slump" in Stocks, Exchange Rates, and Bonds?
Many investors and analysts assert that the UK economy is on the brink of collapse, with its assets facing a "triple slump" across stocks, foreign exchange, and bonds.TradingKey
Mon, Oct 6
JPMorgan Chase & Co. 2025 Second Quarter Earnings Comments
TradingKey - JPMorgan Chase expects full-year 2025 NII to reach approximately $95.5 billion, up $1 billion from prior guidance, including market-related NII of about $3.5 billion. This guidance reflects optimism about the interest rate environment and loan growth, demonstrating confidence in...TradingKey
Wed, Jul 16
Which Crypto Companies Are Filing for IPOs — and Who Might Be the Next Circle?
Circle’s IPO has opened the floodgates for crypto firms to tap public markets. From Gemini and Bullish to Kraken and ConsenSys, the next wave of listings is already forming.TradingKey
Fri, Jun 27
Will Trump’s Tax Bill Benefit American Citizens? 3 Major Controversies: SALT, Medicaid Cuts, and Fiscal Deficits
TradingKey - Key questions remain: Does the U.S. still have room for further tax cuts amid its massive fiscal deficit? Will adjustments to the State and Local Tax (SALT) cap truly benefit ordinary Americans or merely enrich the wealthy? Can Congress and society accept the welfare cuts? Will the...TradingKey
Fri, May 23
